Stay updated on DMD Gene Therapy Safety Study Clinical Trial
Sign up to get notified when there's something new on the DMD Gene Therapy Safety Study Clinical Trial page.

Latest updates to the DMD Gene Therapy Safety Study Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page footer now identifies the site as revision v3.8.1 instead of v3.8.0.SummaryDifference0.1%

- Check9 days agoChange DetectedThe completed SRP-9001-101 study record is now displayed, describing a delandistrogene moxeparvovec gene-therapy trial for Duchenne muscular dystrophy, including its participant criteria, treatment plan, outcome measures, and study documents. Previously, the page showed a 403 error.SummaryDifference46%

- Check16 days agoChange DetectedThe site footer now displays revision v3.8.0 instead of v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedA general NIH banner about its website transition was added, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference1%

- Check44 days agoChange DetectedThe footer now displays site revision v3.7.1 instead of v3.7.0, while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check58 days agoChange DetectedThe study page now shows a 403 Forbidden error, preventing access to the study details that were previously visible. This renders the page content inaccessible until the access issue is resolved.SummaryDifference18%

Stay in the know with updates to DMD Gene Therapy Safety Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DMD Gene Therapy Safety Study Clinical Trial page.